Neurable, the leader in noninvasive brain-computer interface (BCI) technology designed for everyday life, announced it has closed a $35 million Series A round to accelerate the commercialization of Neurable AI, the company's patented compact brain-signal processing technology that seamlessly integrates BCI capabilities into the devices people already use every day. This brings the company's total funds raised to $65 million. The round, led by Spectrum Moonshot Fund, fuels Neurable's next stage of growth as the company brings advanced neurotechnology out of the lab and into daily routines, making brain insights as accessible as heart-rate or sleep tracking.